Literature DB >> 11087668

Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines.

W G Fong1, P Liston, E Rajcan-Separovic, M St Jean, C Craig, R G Korneluk.   

Abstract

X-linked inhibitor of apoptosis protein (XIAP) is a potent modulator of programmed cell death. XIAP specifically binds and inhibits the function of caspase-3, -7, and -9, key effector proteases of apoptosis. We recently isolated, by yeast two-hybrid screening, a novel 34-kDa zinc finger protein, XIAP-associated factor 1 (XAF1). Both the caspase inhibiting and the anti-apoptotic abilities of XIAP were found to be blocked by overexpressed XAF1. Here, we report the isolation and characterization of the human XAF1 gene. The xaf1 gene consists of seven exons spanning 18 kb. Fluorescence in situ hybridization analysis localized the xaf1 locus at 17p13.2, telomeric to the p53 gene. The xaf1 locus was further refined to YAC 746C10, approximately 3 cM distal to TP53. Microsatellite analysis of the xaf1 locus using the NCI 60 cell line panel revealed significantly decreased heterozygosity at all three polymorphic markers tested, suggesting that allelic loss of the xaf1 gene is prevalent in cancer cell lines. Examination of the same NCI cell line panel for xaf1 RNA expression demonstrated that cancer cell lines exhibited very low levels of mRNA relative to normal human liver. In contrast, XIAP mRNA levels were relatively high in the majority of cancer cell lines tested. We propose that a high level of XIAP to XAF1 expression in cancer cells may provide a survival advantage through the relative increase of XIAP anti-apoptotic function. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087668     DOI: 10.1006/geno.2000.6364

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  55 in total

Review 1.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

2.  Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP.

Authors:  Yan Xia; Rachel Novak; Jennifer Lewis; Colin S Duckett; Andrew C Phillips
Journal:  Mol Cell Biochem       Date:  2006-01-24       Impact factor: 3.396

3.  Chemosensitization effects of simultaneous suppression of MDR1 and XIAP in multidrug resistant glioma cells.

Authors:  Zhiqing Zhang; Xiaofang Wang; Suping Wang
Journal:  Med Oncol       Date:  2008-01-23       Impact factor: 3.064

4.  Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions.

Authors:  Cheol-Hee Shin; Min-Goo Lee; Jikhyon Han; Seong-In Jeong; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

5.  Domain organization of XAF1 and the identification and characterization of XIAP(RING) -binding domain of XAF1.

Authors:  Man Kit Tse; Chi Kong Cho; Wai Fung Wong; Bing Zou; Sin Kam Hui; Benjamin Chun Yu Wong; Kong Hung Sze
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

6.  XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.

Authors:  Min-Goo Lee; Jikhyon Han; Seong-In Jeong; Nam-Gu Her; Jin-Hee Lee; Tae-Kyu Ha; Min-Ju Kang; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 7.  Apoptotic cell signaling in cancer progression and therapy.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  Integr Biol (Camb)       Date:  2011-02-22       Impact factor: 2.192

Review 8.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

9.  Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.

Authors:  Fiona M Foster; Thomas W Owens; Jolanta Tanianis-Hughes; Robert B Clarke; Keith Brennan; Nigel J Bundred; Charles H Streuli
Journal:  Breast Cancer Res       Date:  2009-06-29       Impact factor: 6.466

10.  The 6q22.33 locus and breast cancer susceptibility.

Authors:  Tomas Kirchhoff; Zhang-qun Chen; Bert Gold; Prodipto Pal; Mia M Gaudet; Kristi Kosarin; Douglas A Levine; Peter Gregersen; Sara Spencer; Megan Harlan; Mark Robson; Robert J Klein; Clifford A Hudis; Larry Norton; Michael Dean; Kenneth Offit
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.